Nasdaq
$0.8100▼ 1.66%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $4.3MShares out 5.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
16- 2d agoAfter-hours26.10.23 07:454Ownership#●●●
SenesTech, Inc.
GLENBROOK CAPITAL MANAGEMENT, an insider of SenesTech, Inc., reported a change in their beneficial ownership of securities as of October 20, 2026. This filing is a Form 4 statement detailing the adjustment in the insider's holdings.…more
$0.8100-1.66%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 2d agoAfter-hours26.10.23 07:35SCHEDULE 13D/AOwnership
SenesTech, Inc.
The reporting person for SenesTech acquired a total of 103,875 shares of common stock through open market purchases between October 20 and October 22, 2026. The shares were purchased at weighted average prices of $0.6746 on Oct 20, $0.7385 on Oct 21, and $0.7986 on Oct 22, increasing their stake in the company.…more
$0.8100-1.66%vs prev closeView filingShare - 2d agoRegular26.10.23 01:328-KKey event
SenesTech, Inc.
SenesTech has received a delisting determination notice from Nasdaq for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company must regain compliance by April 19, 2027, by maintaining a closing bid price of at least $1.00 for 10 consecutive business days, while reporting record preliminary Q3 revenue of approximately $1.1 million.…more
$0.8100-1.66%vs prev closeView filingShare
15 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoRegular26.10.23 01:30Bullish#●●●#●●●
SenesTech Receives Nasdaq Delisting Warning Despite Record Q3 Revenue
SenesTech has received a Nasdaq deficiency notice for its share price falling below $1.00, though it reported record third-quarter revenue. The company is exploring options to regain compliance, but investors should remain cautious regarding potential dilution from future financing.…more
$0.8100-1.66%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 5d agoRegular26.10.20 04:06
●●●●●●●● ●●●●● ●●●●●●
Glenbrook Capital, holding over 30% of SenesTech, has urged management to improve marketing strategies and enforce capital discipline to prevent further equity dilution. The firm expressed support for the company's growth but emphasized the need to end the cycle of dilutive offerings and reverse splits.…more
$0.8100-1.66%vs prev closeShareBenzinga - 6d agoPre-market26.10.19 21:11
●●●●●●●● ●●●●● ●●●●●●
SenesTech's Evolve rat birth control demonstrated an 88% reduction in rat activity during a 12-month pilot program in Chicago. The company also reported record quarterly revenue of $1.1 million, marking a 55% year-over-year increase.…more
$0.8100-1.66%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report